2183 logo

Linical Co., Ltd. Stock Price

TSE:2183 Community·JP¥6.8b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

2183 Share Price Performance

JP¥302.00
-41.00 (-11.95%)
JP¥302.00
-41.00 (-11.95%)
Price JP¥302.00

2183 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet average dividend payer.

3 Risks
0 Rewards

Linical Co., Ltd. Key Details

JP¥9.9b

Revenue

JP¥7.7b

Cost of Revenue

JP¥2.1b

Gross Profit

JP¥3.3b

Other Expenses

-JP¥1.2b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Dec 05, 2025
-52.51
21.61%
-12.02%
31.4%
View Full Analysis

About 2183

Founded
2005
Employees
598
CEO
Kazuhiro Hatano
WebsiteView website
www.linical.com/ja

Linical Co., Ltd., a global contract research organization provides full spectrum of drug development services to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariats; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan.

Recent 2183 News & Updates

Linical's (TSE:2183) Dividend Will Be ¥16.00

Dec 01
Linical's (TSE:2183) Dividend Will Be ¥16.00

Recent updates

No updates